PS
P SAMPATH KUMAR Dirigeant
Other
IN IN · SEBI (PIT + SAST)
Discover the detailed record of transactions filed by P SAMPATH KUMAR, Dirigeant. Officer active across 1 companies, notably Gland Pharma Limited. In total, 23 reports have been published. The latest transaction was disclosed on 28 June 2022 — Sale. Regulator: SEBI (PIT + SAST). All data is free.
Declarations 23 total
€75,323 2,383 shares @ €31.6084
Equity Shares
SEBI:cddb0aeb785e6e0211c36245ad906c58d4bcf12d · 28 Jun 2022
€547 17 shares @ €32.2028
Equity Shares
SEBI:68a80f928b0e5b685b11e2181f8f3c11f30c2faf · 24 Jun 2022
€77,439 2,400 shares @ €32.2661
Equity Shares
SEBI:bbaccbab5ebffe19d8ecc6ebb59a43718536a259 · 24 Jun 2022
€31,799 4,800 shares @ €6.6249
Equity Shares
SEBI:cd07f5537e2f18a2a6d9dfe549ca4b82d1563536 · 15 Jun 2022
Ideal exit: 12 Mar 2023 (T+270) €205,914 6,000 shares @ €34.3189
Equity Shares
SEBI:ff68bb1554897630c471b7367ec46e077a52fc42 · 25 May 2022
€40,348 6,000 shares @ €6.7246
Equity Shares
SEBI:3b538bb480e7fbe08e30711de45eb45156a70b6f · 29 Apr 2022
Ideal exit: 24 Jan 2023 (T+270) €10,936 280 shares @ €39.0586
Equity Shares
SEBI:93a3f802aaf5fdd00b3324d59ca24e90b8195ece · 29 Mar 2022
€50,196 1,300 shares @ €38.6127
Equity Shares
SEBI:584b4005400299f6af1043b2aea8077a10d331df · 28 Mar 2022
€3,925 100 shares @ €39.2502
Equity Shares
SEBI:84a474d946760e4d3dc97c0f9d1b754f473c9ad4 · 23 Mar 2022
€27,023 600 shares @ €45.039
Equity Shares
SEBI:160b16fa96830e0093e5033eacdf22f878b14907 · 23 Dec 2021
€98,231 2,300 shares @ €42.7089
Equity Shares
SEBI:d9215a99e14eeb2d668dcb60b3c54ce2a1c22e9e · 17 Dec 2021
€13,552 320 shares @ €42.3499
Equity Shares
SEBI:82f89390538c200df7b547265af3fa8fd88c67f0 · 14 Dec 2021
€12,649 300 shares @ €42.1641
Equity Shares
SEBI:a7eb451545adb564e73b99a04f5dea9c6f0fd7b5 · 10 Dec 2021
€8,508 200 shares @ €42.5394
Equity Shares
SEBI:ffd3ebdd48eb4f4e40d229ac84af42f7a8e6eb79 · 6 Dec 2021
€12,409 300 shares @ €41.3635
Equity Shares
SEBI:18aac2f1ab655876e3d6c94ab08fa8f369ea7032 · 15 Nov 2021
€46,117 1,000 shares @ €46.1166
Equity Shares
SEBI:7b93b205c11a207f9cc69653e46cdf4c73e43e63 · 15 Sept 2021
€275,313 6,000 shares @ €45.8856 0.0001% mcap 49.0% of flow
Equity Shares
SEBI:e78cfe191a241e532af44288cfd6085264d84128 · 26 Jul 2021
€41,151 6,700 shares @ €6.1419 0.0000% mcap 100.0% of flow
Equity Shares
SEBI:572b379b59902a26ccb32a61b633330f502096c6 · 5 Jul 2021
Ideal exit: 1 Apr 2022 (T+270) €161,501 4,400 shares @ €36.7049 0.0001% mcap 97.8% of flow
Equity Shares
SEBI:1f4ec0bf778ae86584e6577189bcb5e05fabafd3 · 28 May 2021
€3,698 100 shares @ €36.9787 0.0000% mcap 2.2% of flow
Equity Shares
SEBI:915905fb3fd9d12bb3153c84adfaf973742860ab · 27 May 2021
€37,243 1,000 shares @ €37.2428 0.0000% mcap 6.6% of flow
Equity Shares
SEBI:16be218a5b5786e6989ccaada1caabe9b1554864 · 26 May 2021
€107,413 3,000 shares @ €35.8044 0.0000% mcap 19.1% of flow
Equity Shares
SEBI:88f3fdd382011b4a31bbbfe5542b73f2d182145b · 24 May 2021
€142,004 4,000 shares @ €35.501 0.0001% mcap 25.3% of flow
Equity Shares
SEBI:9bf6237085331d17b3f513780286909dac131e16 · 21 May 2021
About P SAMPATH KUMAR P Sampath Kumar is an executive at Gland Pharma Limited, a company specializing in the manufacturing of pharmaceutical products. He is involved in managing operations and developing strategies to improve efficiency and product quality. His role is essential for meeting industry standards and customer expectations.